Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
Fiorino F, Ciabattini A, Sicuranza A, Pastore G, Santoni A, Simoncelli M, Polvere J, Galimberti S, Baratè C, Sammartano V, Montagnani F, Bocchia M, Medaglini D. Fiorino F, et al. Among authors: polvere j. Front Immunol. 2022 Sep 29;13:1017863. doi: 10.3389/fimmu.2022.1017863. eCollection 2022. Front Immunol. 2022. PMID: 36248803 Free PMC article.
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine.
Ciabattini A, Pastore G, Fiorino F, Polvere J, Lucchesi S, Pettini E, Auddino S, Rancan I, Durante M, Miscia M, Rossetti B, Fabbiani M, Montagnani F, Medaglini D. Ciabattini A, et al. Among authors: polvere j. Front Immunol. 2021 Sep 28;12:740708. doi: 10.3389/fimmu.2021.740708. eCollection 2021. Front Immunol. 2021. PMID: 34650563 Free PMC article.
The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose.
Fiorino F, Sicuranza A, Ciabattini A, Santoni A, Pastore G, Simoncelli M, Polvere J, Galimberti S, Auddino S, Baratè C, Montagnani F, Sammartano V, Bocchia M, Medaglini D. Fiorino F, et al. Among authors: polvere j. Biomedicines. 2021 Oct 15;9(10):1480. doi: 10.3390/biomedicines9101480. Biomedicines. 2021. PMID: 34680595 Free PMC article.
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
Pastore G, Polvere J, Fiorino F, Lucchesi S, Montesi G, Rancan I, Zirpoli S, Lippi A, Durante M, Fabbiani M, Tumbarello M, Montagnani F, Medaglini D, Ciabattini A. Pastore G, et al. Among authors: polvere j. Expert Rev Vaccines. 2024 Jan-Dec;23(1):432-444. doi: 10.1080/14760584.2024.2333952. Epub 2024 Apr 2. Expert Rev Vaccines. 2024. PMID: 38517153 Free article.
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine.
Ciabattini A, Pastore G, Lucchesi S, Montesi G, Costagli S, Polvere J, Fiorino F, Pettini E, Lippi A, Ancillotti L, Tumbarello M, Fabbiani M, Montagnani F, Medaglini D. Ciabattini A, et al. Among authors: polvere j. Cells. 2023 Jun 23;12(13):1706. doi: 10.3390/cells12131706. Cells. 2023. PMID: 37443740 Free PMC article.
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV.
Polvere J, Fabbiani M, Pastore G, Rancan I, Rossetti B, Durante M, Zirpoli S, Morelli E, Pettini E, Lucchesi S, Fiorino F, Tumbarello M, Ciabattini A, Montagnani F, Medaglini D. Polvere J, et al. Commun Med (Lond). 2023 Jan 30;3(1):13. doi: 10.1038/s43856-023-00245-5. Commun Med (Lond). 2023. PMID: 36717688 Free PMC article.